Putnam Investments’s Xenon Pharmaceuticals XENE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q4 | $9.93M | Buy |
215,545
+43,609
| +25% | +$2.01M | 0.01% | 327 |
|
|
2023
Q3 | $5.87M | Buy |
171,936
+6,674
| +4% | +$228K | 0.01% | 405 |
|
|
2023
Q2 | $6.36M | Buy |
165,262
+11,807
| +8% | +$455K | 0.01% | 404 |
|
|
2023
Q1 | $5.49M | Buy |
153,455
+795
| +0.5% | +$28.5K | 0.01% | 427 |
|
|
2022
Q4 | $6.02M | Buy |
152,660
+23,376
| +18% | +$922K | 0.01% | 397 |
|
|
2022
Q3 | $4.67M | Buy |
+129,284
| New | +$4.67M | 0.01% | 450 |
|